Advertisement

Conventional Surgical Management of Primary Hyperparathyroidism

  • Leslie S. Wu
  • Sanziana Roman
Chapter

Abstract

Primary hyperparathyroidism is the most common form of hyperparathyroidism (HPTH) and is the most frequent explanation for hypercalcemia in the outpatient setting. Population-based estimates reveal an overall incidence of approximately 25 per 100,000 in the general population, with 50,000 new annual cases. The peak incidence is in the fifth and sixth decades of life, with a female to male ratio of 3:1. Some studies have estimated the overall prevalence of HPTH in the elderly at 2–3%, with approximately 200 cases/100,000 population.

Parathyroidectomy with bilateral neck exploration (BNE) has been the treatment of choice for primary HPTH for many decades. With the advent of new preoperative and intraoperative parathyroid localization modalities, the concept of “focused” or minimally invasive parathyroidectomy has become commonplace. Nonetheless, an understanding of the conventional surgical management remains paramount for the successful treatment of primary HPTH. This time-tested dissection by an experienced endocrine surgeon continues to be the gold standard to which all other procedures are compared.

Keywords

Parathyroid Gland Recurrent Laryngeal Nerve Parathyroid Carcinoma Parathyroid Tissue Parathyroid Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rodgers SE, Lew JI, Solorzano CC (2008) Primary hyperparathyroidism. Curr Opin Oncol 20:52–58PubMedCrossRefGoogle Scholar
  2. 2.
    Adami S, Marcocci C, Gatti D (2002) Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 17(Suppl 2):N18–N23PubMedGoogle Scholar
  3. 3.
    Hindie E, Ugar O, Fuster D et al (2009) 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 36:1201–1216PubMedCrossRefGoogle Scholar
  4. 4.
    Chen JD, Morrison C, Zhang C et al (2003) Hyperparathyroidism-jaw tumour syndrome. J Intern Med 253:634–642PubMedCrossRefGoogle Scholar
  5. 5.
    Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1999) Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985–1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 86:538–544PubMedCrossRefGoogle Scholar
  6. 6.
    Rodgers SE, Perrier ND (2006) Parathyroid carcinoma. Curr Opin Oncol 18:16–22PubMedCrossRefGoogle Scholar
  7. 7.
    Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333:166–174PubMedCrossRefGoogle Scholar
  8. 8.
    Diamond TW, Botha JR, Wing J, Meyers AM, Kalk WJ (1986) Parathyroid hypertension: a reversible disorder. Arch Intern Med 146:1709–1712PubMedCrossRefGoogle Scholar
  9. 9.
    Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR (2009) Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:351–365PubMedCrossRefGoogle Scholar
  10. 10.
    Patten BM, Bilezikian JP, Mallette LE et al (1974) Neuromuscular disease and primary hyperparathyroidism. Ann Intern Med 80:182–193PubMedGoogle Scholar
  11. 11.
    Petersen P (1968) Psychiatric disorders in primary hyperparathyroidism. J Clin Endocrinol Metab 28:1491–1495PubMedCrossRefGoogle Scholar
  12. 12.
    Schram MT, Trompet S, Kamper AM et al (2007) Serum calcium and cognitive function in old age. J Am Geriatr Soc 55:1786–1792PubMedCrossRefGoogle Scholar
  13. 13.
    Potts JT Jr, Fradkin JE, Aurbach GD, Bilezikian JP, Raisz LG (1990) Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism. J Bone Miner Res 6(Suppl 2):S1–S166Google Scholar
  14. 14.
    Bilezikian JP, Potts JT Jr, Fuleihan GH et al (2002) Summary statement of a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17(Suppl 2):N2–N11PubMedGoogle Scholar
  15. 15.
    Kouvaraki MA, Greer M, Sharma S et al (2006) Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. Surgery 139:527–534PubMedCrossRefGoogle Scholar
  16. 16.
    Walker MD, McMahon DJ, Inabnet WB (2009) Neuropsychological features in primary hyperparathyroidism: a prospective study. J Clin Endocrinol Metab 94:1951–1958PubMedCrossRefGoogle Scholar
  17. 17.
    Roman SA, Sosa JA, Mayes L et al (2005) Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery 138:1121–1128PubMedCrossRefGoogle Scholar
  18. 18.
    Zanocco K, Angelos P, Sturgeon C (2006) Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery 140:874–881PubMedCrossRefGoogle Scholar
  19. 19.
    Zanocco K, Sturgeon C (2008) How should age at diagnosis impact treatment strategy in asymptomatic primary hyperparathyroidism? A cost-effectiveness analysis. Surgery 144:290–298PubMedCrossRefGoogle Scholar
  20. 20.
    Udelsman R, Pasieka JL, Sturgeon C, Young JEM, Clark OH (2009) Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 94:366–372PubMedCrossRefGoogle Scholar
  21. 21.
    Bilezikian JP, Khan AA, Potts JT et al (2009) Guidelines for the management of asymptomatic hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab 94(2):335–339PubMedCrossRefGoogle Scholar
  22. 22.
    Proye C, Carnaille B, Quievreux JL et al (1998) Late outcome of 304 consecutive patients with multiple gland enlargement in primary hyperparathyroidism treated by conservative surgery. World J Surg 22:526–529PubMedCrossRefGoogle Scholar
  23. 23.
    van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692PubMedCrossRefGoogle Scholar
  24. 24.
    Guerrero MA, Wray CJ, Kee SS, Frenzel JC, Perrier ND (2007) Minimally invasive parathyroidectomy complicated by pneumothoraces: a report of 4 cases. J Surg Educ 64:101–107PubMedCrossRefGoogle Scholar
  25. 25.
    Chen H, Sokoll LJ, Udelsman R (1999) Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 126:1016–1021PubMedCrossRefGoogle Scholar
  26. 26.
    Chen H, Mack E, Starling JR (2003) Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg 238:332–338PubMedCrossRefGoogle Scholar
  27. 27.
    Miccoli P, Bendinelli C, Vignali E et al (1998) Endoscopic parathyroidectomy: report on an initial experience. Surgery 124:1077–1079PubMedCrossRefGoogle Scholar
  28. 28.
    Irvin GL, Sfakianakis G, Yeung L et al (1996) Ambulatory parathyroidectomy for primary hyperparathyroidism. Arch Surg 31:1074–1078CrossRefGoogle Scholar
  29. 29.
    Lew JI, Solorzano CC (2009) Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am 89:1205–1225PubMedCrossRefGoogle Scholar
  30. 30.
    Udelsman R, Lin Z, Donovan P (2011) The superiority of minimally invasive parathyroidectomy based on 1,650 consecutive patients with primary hyperparathyroidism. Ann Surg 253:585–591PubMedCrossRefGoogle Scholar
  31. 31.
    Bendz H, Sjodin I, Toss G, Berglund K (1996) Hyperparathyroidism and long-term lithium therapy: a cross-sectional study and the effect of lithium withdrawal. J Intern Med 240:357–365PubMedCrossRefGoogle Scholar
  32. 32.
    Lo Gerfo P (1999) Bilateral neck exploration for parathyroidectomy under local anesthesia: a viable technique for patients with coexisting thyroid disease with or without sestamibi scanning. Surgery 126:1011–1014PubMedCrossRefGoogle Scholar
  33. 33.
    Krempl G, Medina JE, Bouknight AL (2003) Surgical management of the parathyroids. Otolaryngol Clin North Am 36:217–228PubMedCrossRefGoogle Scholar
  34. 34.
    Bonjer HJ, Bruining HA (2005) Technique of parathyroidectomy. In: Clark OH, Duh QY, Kebebew E (eds) Textbook of endocrine surgery, 2nd edn. Elsevier Saunders, Philadelphia, pp 439–448CrossRefGoogle Scholar
  35. 35.
    Elliott DD, Monroe DP, Perrier ND (2006) Parathyroid histopathology: is it of any value today? J Am Coll Surg 203:758–765PubMedCrossRefGoogle Scholar
  36. 36.
    Iacobone M, Scarpa M, Lumachi F et al (2005) Are frozen sections useful and cost-effective in the era of intraoperative qPTH assays? Surgery 138:1159–1164PubMedCrossRefGoogle Scholar
  37. 37.
    Irvin GL, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162:299–302PubMedCrossRefGoogle Scholar
  38. 38.
    Kaplan EL, Bartlett S, Sugimoto J, Fredland A (1982) Relation of postoperative hypocalcemia to operative techniques: deleterious effect of excessive use of parathyroid biopsy. Surgery 92:827–834PubMedGoogle Scholar
  39. 39.
    Irvin GL, Dl P, Deriso GT et al (1994) A new approach to parathyroidectomy. Ann Surg 219:574–579PubMedCrossRefGoogle Scholar
  40. 40.
    Akerstrom G, Rudberg C, Grimelius L, Rastad J (1992) Causes of failed primary exploration and technical aspects of re-operation in primary hyperparathyroidism. World J Surg 16:562–568PubMedCrossRefGoogle Scholar
  41. 41.
    Uludag M, Isgor A, Yetkin G et al (2009) Supernumerary ectopic parathyroid glands: persistent hyperparathyroidism due to mediastinal parathyroid adenoma localized by preoperative single photon emission computed tomography and intraoperative gamma probe application. Hormones 8:144–149PubMedGoogle Scholar
  42. 42.
    Mittendorf EA, McHenry CR (2002) Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 128:275–279PubMedGoogle Scholar
  43. 43.
    Sheldon DG, Lee FT, Neil NJ, Ryan JA Jr (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137:1022–1028PubMedCrossRefGoogle Scholar
  44. 44.
    Cannon J, Lew JI, Solorzano CC (2010) Parathyroidectomy for hypercalcemic crisis: 40 years’ experience and long-term outcomes. Surgery 148:807–813PubMedCrossRefGoogle Scholar
  45. 45.
    Peacock M, Bilezikian JP, Turner SA et al (2003) Cinacalcet hyperochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 90:135–141CrossRefGoogle Scholar
  46. 46.
    Lew JI, Rivera M, Irvin GL, Solorzano CC (2010) Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg 145:628–633PubMedCrossRefGoogle Scholar
  47. 47.
    Irvin GL, Carniero DM, Solorzano CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239:704–711PubMedCrossRefGoogle Scholar
  48. 48.
    Westerdahl J, Bergenfelz A (2007) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: five-year follow-up of a randomized controlled trial. Ann Surg 246:976–981PubMedCrossRefGoogle Scholar
  49. 49.
    Vestergaard P, Mosekilde L (2003) Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. Br Med J 327:530–534CrossRefGoogle Scholar
  50. 50.
    Tamura Y, Araki A, Chiba Y et al (2007) Remarkable increase in lumbar spine bone mineral density and amelioration in biochemical markers of bone turnover after parathyroidectomy in elderly patients with primary hyperparathyroidism: a 5-year follow-up study. J Bone Miner Metab 25:226–231PubMedCrossRefGoogle Scholar
  51. 51.
    Roman SA, Sosa JA (2007) Psychiatric and cognitive aspects of primary hyperparathyroidism. Curr Opin Oncol 19:1–5PubMedCrossRefGoogle Scholar
  52. 52.
    Talpos GB, Bone HG, Kleerekoper M et al (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 125:1013–1021CrossRefGoogle Scholar
  53. 53.
    Pasieka JL, Parsons LL, Demeure MJ et al (2002) Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26:942–949PubMedCrossRefGoogle Scholar
  54. 54.
    Hedback G, Oden A (1998) Increased risk of death from primary hyperparathyroidism – an update. Eur J Clin Invest 28:271–276PubMedCrossRefGoogle Scholar
  55. 55.
    Norenstedt S, Ekbom A, Brandt L, Zedenius J, Nilsson IL (2009) Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients. Eur J Endocrinol 160:295–299PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Department of SurgeryMaine Medical CenterPortlandUSA
  2. 2.Department of SurgeryYale University School of MedicineNew HavenUSA

Personalised recommendations